| The incidence, complications, and treatment of iron deficiency in pregnancy AE Benson, JJ Shatzel, KS Ryan, MA Hedges, K Martens, JE Aslan, JO Lo European journal of haematology 109 (6), 633-642, 2022 | 39 | 2022 |
| Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions AH Arastu, BK Elstrott, KL Martens, JL Cohen, MH Oakes, ZT Rub, ... JAMA network open 5 (3), e224488-e224488, 2022 | 34 | 2022 |
| The role of oral iron in the treatment of adults with iron deficiency JO Lo, AE Benson, KL Martens, MA Hedges, HS McMurry, T DeLoughery, ... European Journal of Haematology 110 (2), 123-130, 2023 | 21 | 2023 |
| Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia KL Martens, PR Khalighi, S Li, AA White, E Silgard, D Frieze, E Estey, ... Leukemia Research 89, 106298, 2020 | 15 | 2020 |
| HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment KL Martens, WL da Costa Jr, CI Amos, C Davis, M Kesten, SJ Lee, ... Blood advances 5 (1), 167-175, 2021 | 13 | 2021 |
| Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation KL Martens, CI Amos, CR Hernandez, P Kebriaei, WL da Costa Jr, ... American journal of hematology 96 (9), 1137-1146, 2021 | 8 | 2021 |
| Platelet reactivity and platelet count in women with iron deficiency treated with intravenous iron BK Elstrott, HHS Lakshmanan, AR Melrose, KR Jordan, KL Martens, ... Research and Practice in Thrombosis and Haemostasis 6 (2), e12692, 2022 | 7 | 2022 |
| Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis H McMurry, JMG Sabile, B Elstrott, B Chobrutskiy, A Mohinani, S Patel, ... Thrombosis research 216, 1-7, 2022 | 6 | 2022 |
| Utilization patterns and clinical outcomes of rasburicase administration according to tumor risk stratification PR Khalighi, KL Martens, AA White, S Li, E Silgard, D Frieze, DA Garcia, ... Journal of Oncology Pharmacy Practice 26 (3), 529-535, 2020 | 6 | 2020 |
| Anticoagulation in cirrhosis: evidence for the treatment of portal vein thrombosis and applications for prophylactic therapy K Martens, HS McMurry, S Koprowski, J Hum, J Haraga, JH Jou, ... Journal of clinical gastroenterology 56 (6), 536-545, 2022 | 5 | 2022 |
| Sex, lies, and iron deficiency: a call to change ferritin reference ranges K Martens, TG DeLoughery Hematology 2023 (1), 617-621, 2023 | 3 | 2023 |
| Epidemiology of cancer-associated venous thromboembolism in patients with solid and hematologic neoplasms in the veterans affairs health care system KL Martens, A Li, J La, SB May, KN Swinnerton, H Tosi, DC Elbers, NV Do, ... JAMA Network Open 6 (6), e2317945-e2317945, 2023 | 2 | 2023 |
| Clinical outcomes of patients referred for asymptomatic neutropenia at a single academic center: a focus on racial disparities E Oyogoa, KL Martens, HS McMurry, CM Lavasseur, SR Olson, ... Blood 140 (Supplement 1), 5119-5120, 2022 | 2 | 2022 |
| Challenging clinical scenarios for therapeutic anticoagulation: A practical approach KL Martens, SE Dekker, M Crowe, TG DeLoughery, JJ Shatzel Thrombosis research 218, 72-82, 2022 | 2 | 2022 |
| Incidence, mechanism, and consequences of IV iron–induced hypophosphatemia KL Martens, M Wolf Hematology 2023 (1), 636-639, 2023 | 1 | 2023 |
| Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation J Avery, D Guffey, S Ma, R Basom, SJ Lee, D Garcia, CMR Hernandez, ... Thrombosis Research 229, 1-6, 2023 | 1 | 2023 |
| Venous thromboembolism risk in cancer patients receiving first‐line immune checkpoint inhibitor versus chemotherapy A Li, SB May, J La, KL Martens, CI Amos, CR Flowers, NV Do, MT Brophy, ... American journal of hematology 98 (8), 1214-1222, 2023 | 1 | 2023 |
| Clinical outcomes of patients referred for asymptomatic neutropenia: A focus on racial disparities in hematology E Oyogoa, R Mathews, S Olson, T DeLoughery, JJ Shatzel, KL Martens European Journal of Haematology 111 (1), 41-46, 2023 | 1 | 2023 |
| External validation of the HIGH‐2‐LOW model: A predictive score for venous thromboembolism after allogeneic transplant A Li, KL Martens, D Nguyen, R Basom, G Rondon, S Jin, E Young, ... American journal of hematology 97 (6), 740-748, 2022 | 1 | 2022 |
| Dermatologic manifestations of hematologic disorders HL King, GB Benedetti, JJ Keller, TG DeLoughery, JJ Shatzel, KL Martens Annals of Hematology, 1-15, 2024 | | 2024 |
